PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8889763-5	1996	We observed that insulin infusion significantly increased the rate of systemic glucose utilization (P < 0.01) and also significantly decreased the ratio of inorganic phosphate to phosphocreatine (P < 0.001) during forearm exercise compared with the control study.	Phosphocreatine	182-197	insulin	Homo sapiens	17-24	
17384336-6	2007	The phosphocreatine-to-ATP ratio was reduced across increasing quartiles of mean +/- SD BMI (2.25 +/- 0.52, 1.89 +/- 0.26, 1.99 +/- 0.38, and 1.79 +/- 0.29; P < 0.006) in association with insulin sensitivity (computer homeostasis model assessment 2 model); this relation was independent of age, BMI, blood pressure, wall mass, HDL cholesterol, triglycerides, smoking habits, and metabolic syndrome.	Phosphocreatine	4-19	insulin	Homo sapiens	191-198	
24841383-6	2015	IGF-1 and insulin also rescued energy levels in HD peripheral cells, as evaluated by increased ATP and phosphocreatine, and decreased lactate levels.	Phosphocreatine	103-118	insulin	Homo sapiens	10-17	
6379307-12	1984	The mean creatine phosphate content was again significantly (p less than 0.05) higher in the insulin group (6.70 mumol/gm) than in the control group (5.30 mumol/gm).	Phosphocreatine	9-27	insulin	Homo sapiens	93-100	
30366667-0	2018	Phosphocreatine attenuates endoplasmic reticulum stress-mediated hepatocellular apoptosis ameliorates insulin resistance in diabetes model.	Phosphocreatine	0-15	insulin	Homo sapiens	102-109	
26916682-0	2017	The association among skeletal muscle phosphocreatine recovery, adiposity, and insulin resistance in children.	Phosphocreatine	38-53	insulin	Homo sapiens	79-86	
24251951-8	2014	Additionally the insulin-resistance group had a lower log rate of postexercise phosphocreatine (PCr) recovery (ViPCr) and a higher log PCr recovery constant (tau), indicative of impaired MF.	Phosphocreatine	79-94	insulin	Homo sapiens	17-24